![](/img/cover-not-exists.png)
Hepatocyte growth factor reduces sensitivity to the epidermal growth factor receptor-tyrosine kinase inhibitor, gefitinib, in lung adenocarcinoma cells harboring wild-type EGFR
Yang, Hua, Wang, Rong, Peng, Shunli, Chen, Longhua, Li, Qi, Wang, WeiVolume:
7
Language:
english
Journal:
Oncotarget
DOI:
10.18632/oncotarget.7586
Date:
March, 2016
File:
PDF, 5.97 MB
english, 2016